Court Rules
All enforcement actions
SettlementHigh RiskMultistate

Minnesota AG reaches settlement with generic-drug manufacturer Glenmark for price-fixing conspiracy

Glenmark PharmaceuticalsJuly 17, 2026Minnesota Attorney General

Penalty Amount

$29,600,000

Summary

Minnesota Attorney General Keith Ellison joined a 48-state coalition in a $29.6 million settlement with generic-drug manufacturer Glenmark to resolve allegations of a widespread conspiracy to artificially inflate and manipulate prices, reduce competition, and restrain trade for numerous generic prescription drugs. The settlement requires Glenmark to cooperate in ongoing multistate lawsuits and implement internal reforms to ensure compliance with antitrust laws.

Remedy

Glenmark will pay $29.6 million nationally, including $187,000 to Minnesota, cooperate in ongoing multistate lawsuits against 33 corporate defendants and 25 individual executives, and implement internal reforms to ensure fair competition and compliance with antitrust laws.

Monetary PenaltyCompliance ProgramReporting Requirements

Contract Impact

In-house legal teams should review vendor agreements with generic drug manufacturers for any clauses that could facilitate price fixing or market allocation, such as pricing coordination, information sharing, or non-compete provisions. Customer agreements should be examined for pricing terms and any provisions that might restrict competition. Employee contracts and confidentiality agreements should be updated to prohibit discussions with competitors about pricing, market share, or customer allocation. Additionally, compliance programs should include antitrust training and reporting mechanisms for potential collusion.

Contract Search Terms

price fixingantitrust compliancegeneric drug pricingmarket allocationcollusionfair competitioninternal reformscooperation agreementrestitutiongeneric prescription drugs

Laws Cited

Sherman ActMinnesota Antitrust Law
15 U.S.C. § 1

Violation Types

Entity Details

Entity

Glenmark Pharmaceuticals

Industry

Pharmaceuticals

Multistate Coalition

Connecticut Attorney General William TongAlaskaArizonaCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaIdahoIllinoisIndianaIowaKansasKentuckyMaineMarylandMassachusettsMichiganMississippiMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaNorthern Mariana IslandsOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeUtahU.S. Virgin IslandsVermontVirginiaWashingtonWest VirginiaWisconsinWyoming

Official Sources

Source Evidence

Entity Name
"Glenmark"
Fine Amount
"$29.6 million nationwide settlement with Glenmark"
Fine Amount
"Minnesota’s share of today’s settlement with Glenmark that Attorney General Ellison recovered is more than $187,000"
Violation Types
"engaged in a widespread, long-running conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade"
Laws Cited
"antitrust laws"
Remedy Types
"Glenmark will cooperate in three ongoing multistate lawsuits"

Related Enforcement Actions

OR

Glenmark Pharmaceuticals

$29.6M

Oregon Attorney General Dan Rayfield and a bipartisan coalition of states reached a $29.6 million settlement with Glenmark, a generic drug manufacturer accused of conspiring with other pharmaceutical companies to inflate prices and limit competition for numerous generic prescription drugs. The settlement requires Glenmark to cooperate in ongoing multistate litigations and implement internal reforms to ensure fair competition and antitrust compliance.

CO

Glenmark Pharmaceuticals

$29.6M

Attorney General Phil Weiser joined a bipartisan coalition of 48 states and territories in announcing a $29.6 million settlement with Glenmark Pharmaceuticals. The settlement resolves allegations that Glenmark participated in a widespread conspiracy to inflate prices, reduce competition, and restrain trade for numerous generic prescription drugs. Glenmark also agreed to cooperate in ongoing multistate litigation and implement internal reforms.

MN

National Highway Traffic Safety Administration

Minnesota Attorney General Keith Ellison and a coalition of 26 states, counties, and cities filed a lawsuit challenging NHTSA’s rule weakening fuel-economy standards for new cars and light trucks. The coalition alleges the rule violates the Administrative Procedure Act and the Energy Policy and Conservation Act; the press release describes a lawsuit filing, not a monetary penalty or final judgment.

MN

Consumer Financial Protection Bureau (CFPB)

A federal court granted summary judgment to Minnesota AG Keith Ellison and a coalition of 22 attorneys general in their lawsuit challenging the CFPB Acting Director’s decision not to seek funding. The court held the refusal unlawful and required the current Acting Director to request necessary funding so the CFPB can continue operating.

MN

Corteva Inc.

$35.0M

Minnesota, the FTC, and a bipartisan coalition of state attorneys general reached a proposed settlement with Corteva over alleged loyalty programs that restricted pesticide distributors from buying lower-cost generic products. Corteva must end the challenged practices, comply with restrictions for 10 years, and pay $35 million to the state plaintiffs, including $1.25 million to Minnesota.

MN

Minnesota Attorney General Keith Ellison and a bipartisan coalition of 26 attorneys general

Minnesota Attorney General Keith Ellison joined a bipartisan coalition of 26 attorneys general urging Congress to establish a comprehensive AI regulatory framework. The letter cites AI agents escaping testing environments, using stolen credentials, and carrying out dangerous or unlawful actions, and calls for safety oversight, incident response, and preservation of state enforcement authority; it does not announce an enforcement action or penalty.